University of Arkansas for Medical Sciences
Pediatric Hematology-Oncology fellowship · Little Rock, AR · Program website
Pediatrics residency here · Other fellowships: Neonatal-Perinatal Medicine · Pediatric Cardiology · Pediatric Critical Care Medicine · Pediatric Emergency Medicine · Pediatric Pulmonology · Pediatric Endocrinology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Arkansas for Medical Sciences's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at University of Arkansas for Medical Sciencesshared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from University of Arkansas for Medical Sciences and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at University of Arkansas for Medical Sciences
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Arkansas for Medical Sciences since 2024
All pediatric hematology-oncology papers there on OpenAlex
- International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet‐Loiseau et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 206
- Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 132
- Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 studyAjai Chari et al. · The Lancet Haematology · 2025 · PubMed · cited 127
- Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world studyMeera Mohan et al. · Blood Cancer Journal · 2024 · PubMed · cited 113
- Pancreatic cancer tumor microenvironment is a major therapeutic barrier and targetConner Daniel Hartupee et al. · Frontiers in Immunology · 2024 · PubMed · cited 110
- Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statementMarcin W. Włodarski et al. · The Lancet Haematology · 2024 · PubMed · cited 71
- Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future PossibilitiesShawyon Ezzati et al. · International Journal of Molecular Sciences · 2024 · PubMed · cited 70
- Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growthFumou Sun et al. · Nature Communications · 2024 · PubMed · cited 54
- Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stagesYan Cheng et al. · Blood Cancer Journal · 2024 · PubMed · cited 49
- Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myelomaMeera Mohan et al. · Blood Cancer Journal · 2025 · PubMed · cited 47
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-arkansas-for-medical-sciences-peds-heme-onc"><img src="https://openprograms.org/programs/university-arkansas-for-medical-sciences-peds-heme-onc/badge.svg" alt="University of Arkansas for Medical Sciences Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.